• Neurology · Jul 1993

    Review

    Brain embolism, revisited.

    • L R Caplan.
    • Department of Neurology, Tufts University School of Medicine, New England Medical Center, Boston, MA 02111.
    • Neurology. 1993 Jul 1;43(7):1281-7.

    AbstractTreatment of brain embolism should depend on the nature of the embolic material, if discoverable or predictable, not on whether the source was cardiac or intra-arterial. The middle cerebral artery territory is the most common recipient site for emboli, but many emboli do go to the carotid arteries and the posterior circulation. Cardiac and intra-arterial embolism probably each account for about one in five posterior circulation infarcts. Paradoxical embolism is much more common than formerly appreciated. The carotid arteries are probably the most common sources of intra-arterial emboli to the brain, but emboli also frequently arise from the aorta and the vertebral arteries. Potential embolic materials probably frequently enter the circulation but rarely cause strokes.

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.